BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baig MT, Ghufran H, Mehmood A, Azam M, Humayun S, Riazuddin S. Vitamin E pretreated Wharton's jelly-derived mesenchymal stem cells attenuate CCl4-induced hepatocyte injury in vitro and liver fibrosis in vivo. Biochem Pharmacol 2021;186:114480. [PMID: 33617844 DOI: 10.1016/j.bcp.2021.114480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Nemati M, Ebrahimi Z, Abolhassani S, Nemati F, Ebrahimi B, Alizadeh A. The Efficiency of Stem Cells (SCs) Differentiation into Functional Hepatocytes for Treating Liver Disorders: A Systematic Review. Biomed Res Int 2023;2023:4868048. [PMID: 36685673 DOI: 10.1155/2023/4868048] [Reference Citation Analysis]
2 Gao Y, Yin X, Ren X, Najimi M. Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control. Stem Cells International 2022;2022:1-18. [DOI: 10.1155/2022/1526217] [Reference Citation Analysis]
3 Shao B, Qin YF, Ren SH, Peng QF, Qin H, Wang ZB, Wang HD, Li GM, Zhu YL, Sun CL, Zhang JY, Li X, Wang H. Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis. Front Immunol 2022;13:859972. [PMID: 35663940 DOI: 10.3389/fimmu.2022.859972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]